TheDeletion Polymorphism oftheAngiotensin I-Converting...
-
Upload
vuongkhanh -
Category
Documents
-
view
227 -
download
0
Transcript of TheDeletion Polymorphism oftheAngiotensin I-Converting...
2550 Volume 7 - Number 12 - 1996
The Deletion Polymorphism of the Angiotensin I-ConvertingEnzyme Gene Is Associated with Target Organ Damage inEssential Hypertension1Roberto Pontremoli, Antonella Sofia, Angelito Tirotta, Maura Ravera, Clizia Nicolella,
Francesca Viazzi, Gian Paolo Bezante, Luigi Borgia,
Giorgio Sacchi, and Giacomo Deferrari2
R. Pontremoli. A. Sofia. A. Tirotta. M. Ravera. C.Nicolella. F. Viazzi. G.P. Bezante, G. Deferrari, Depart-ment of Internal Medicine, University of Genoa.Genoa, Italy
L. Borgia. Institute of Ophthalmology. University ofGenoa, Genoa, Italy
N. Bobola, P. Pavazzolo, Institute of Biology and Ge-netics. University of Genoa. Genoa, Italy
G. Sacchi. Institute of Methodology, Economics andStatistics, University of Urbino, Urbino, Italy
(J. Am. Soc. Nephrol. 199#{243};7:2550-2558)
ABSTRACTThe activity of the renin-angiotensin-aldosterone sys-tem is thought to play a significant role in the devel-opment of target organ damage in essential hyper-tension. An insertion/deletion (I/O) polymorphism of
the angiotensin I-converting enzyme (ACE) gene hasrecently been associated with increased risk for leftventricular hypertrophy and coronary heart diseasein the general population. The D allele is associatedwith higher levels of circulating ACE and thereforemay predispose to cardiovascular damage. Thestudy presented here was performed to investigatethe association between the ACE genotype, mi-croalbuminunia, retinopathy, and left ventricular hy-pertrophy in 106 patients with essential hypertension.ACE gene polymorphism was determined by poly-merase chain reaction technique. Microalbuminuniawas evaluated as albumin-to-creatinine ratio (A/C) inthree nonconsecutive first morning urine samples(negative urine culture) after a 4-wk washout period.Microalbuminunia was defined as A/C between 2.38to 19 (men) and 2.96 to 20 (women). Hypertensiveretinopathy was evaluated by direct funduscopicexamination (Keith-Wagener-Barker classification)and left ventricular hypertrophy by M-B mode echo-cardiography. The distribution of the DD, ID, and I!
1 Received April 19, 1996. Accepted July 9. 1996.
2 Correspondence to Dr. G. Deferrari, Department of Internal Medicine, University
of Genoa, Viale Benedetfo XV 6, 16132 Genoa, Italy.
1046.6673/0712-2550103.00/0Journal of the American Society of NephrologyCopyright © 1996 by the American Society of Nephrology
Nicoletta Bobola, Roberto Ravazzolo,
genotypes was 27, 50, and 23%, respectively. Theprevalence of microalbuminunia, retinopathy, andleft ventricular hypertrophy was 19, 74, and 72% re-
spectively. There were no differences among thethree genotypes for age, known duration of disease,
body mass index, blood pressure, serum glucose, uricacid, and lipid profile. DO and ID genotypes weresignificantly associated with the presence of mi-croalbuminunia (odds ratio, 8.51 ; 95% confidenceinterval, 1.07 to 67.85; P = 0.019), retinopathy (oddsratio, 5.19; 95% confidence interval, 1.71 to 15.75; P =0.005) and left ventricular hypertrophy (odds ratio,5.22; 95% confidence interval, 1.52to 17.94; P= 0.016).
Furthermore, patients with DO and ID genotypes
showed higher levels of A/C (3.6 ± 0.9, DO: 2.6 ± 0.7,ID; 0.9 ± 0.2 mg/mmol, II; P = 0.0015 by analysis ofvariance) and increased left ventricular mass index(152 ± 4.7, DD+!D versus 133 ± 5.7 g/m2, II; P = 0.01)compared with I! patients. The 0 allele was signifi-
cantly more frequent in patients with microalbumin-
unia (odds ratio, 2.59; 95% confidence interval, 1.24 to5.41 ; P = 0.013) and in those with retinopathy (oddsratio, 2.44; 95% confidence interval, 1.21 to 4.90; P =0.015). Multiple regression analyses performed
among the entire cohort of patients demonstratedthat ACE genotype significantly and independentlyinfluences the presence of retinopathy, left ventricularhypertrophy, and microalbuminunia. In conclusion,the D allele of the ACE gene is associated with mi-croalbuminunia as well as with retinopathy and left
ventricular hypertrophy, and seems to be an inde-
pendent risk factor for target organ damage in essen-
tial hypertension.
Key Words: ACE gene polymorphism. renin-angiotensin-aldo-
sterone system. left ventricular hypertrophy. retinopathy, mi-croalbuminuria
P atients with essential hypertension are heteroge-
neous in their clinical characteristics and prog-
nosis. Several factors besides the bevel of blood pres-
sure values may contribute to the development of
target organ damage and cardiovascular complica-
tions. Among these factors. an unambiguous role isplayed by the renin-angiotensmn-aldosterone system
( 1 ).
The genes encoding components of the renin-angio-
Pontremoli et al
Journal of the American Society of Nephrology 2551
tensin system are appealing candidates for a signifi-
cant role in the development of cardiovascular damage
in patients with hypertension. The renin-anglotensln-aldosterone system is present in circulating and tis-
sue-based forms and is Involved In sodium homeosta-
515. cardiovascular remodeling, and maintenance of
vascular tone. Angiotensin I-converting enzyme (ACE)
is a key component within the renin-anglotensin-
system. where It hydrolyzes anglotensin I to generate
the powerful vasoconstnictor angiotensin II, and
within the kalllkrein-kinin system, where It macti-
yates the vasodilator bradykinmn. In humans, the
plasma level of ACE is genetically determined. The
ACE gene. which has been mapped to human chro-
mosome 1 7q23. has an insertion/deletion (lID) poby-
morphism In Intron 16. The mean plasma ACE level inDD subjects Is about twice that of II subjects with ID
subjects having intermediate bevels (2.3). Although the
lID polymorphism of the ACE gene is considered to
play a small robe in the pathogenesis of hypertension,
the higher bevels of ACE associated with the D allele
may lead to greater angiotensmn II formation In cardiac
and vascular tissues, predisposing a subject to car-
diovascular damage.
In fact, the DD genotype has recently been reported
to be a risk factor for left ventricular hypertrophy (4,5)
and lschemic heart disease (6,7), both in the general
population and in patients with diabetes mellitus (8),
even though other studies could not confirm this
association (9).
The study presented here was performed to explore
the possibility that ACE gene polymorphism may be
related to the development of target organ damage In
essential hypertension.
METHODS
Study Population
Since January 1994, 106 consecutive patients (all Cauca-sian Europeans) with essential hypertension who were at-tending the outpatient clinic of our institution were asked toparticipate in this study. which was part of a larger clinicaltrial (MAGIC. : Microalbuminuria: A Genoa Investigation
on Complications) approved by the Ethical Committee of ourInstitution. Exclusion criteria were the presence of neoplas-tic. hepatic and/or renal disease, chronic heart failure (NewYork Heart Association Classes III and IV). diabetes mellitus,severe obesity (defined as body weight > 1 50% of ideal bodyweight), disabling diseases (such as dementia), or the inabil-Ity of the patients to cooperate. Diagnosis of essential hyper-
tension was made by the attending physician after complete
medical history, physical examination. and routine blochem-Ical analyses of blood and urine were obtained from everypatient. Further investigation was carried out only whenabnormalities were found In these analyses, or when othersymptoms or signs suggesting secondary hypertension were
present. Hypertension was defined according to Joint Na-tional Committee V criteria as an average blood pressure� 140/90 mm Hg on at least three different occasions. or bythe presence of antlhypertensive treatment. None of thepatients was on drug treatment at the time of the study. Theyhad either never been treated for hypertension or had been
taken off therapy at least 4 wk before the study. Twenty-four
urinary collection was obtained In each patient for the mea-
surement of creatinine and electrolytes On the study day,height and weight were measured. then venous blood was
drawn after an overnight fast in order to measure hemato-chemical parameters. Blood pressure was measured by a
trained nurse on the right arm, with the patient In a sitting
position after a 5-mm rest. with a mercury sphygmomanom-eter (cuff size 1 2.5 x 40 cm). The systolic and diastolic blood
pressures were read to the nearest 2 mm Hg. Disappearance
of Korotkoffs sounds (Phase V) was the criterion for diastolic
blood pressure. The lowest of three consecutive readingswere recorded. Body mass index (BMI) was calculated withthe formula: BMI weight (Kg)/height (m)2. Standard elec-trocardiogram ( 1 2 leads) and funduscopic examination wereobtained for each patient. Creatinine, BUN. electrolytes. uricacid, triglycerides. total and high-density lipoprotein chobes-terol, and other standard chemistry evaluations were per-
formed on serum and urine according to routine methods.Low-density bipoprotein cholesterol was calculated using
Friedewald’s formula ( 10). FamIly history and lifestyle habitswere assessed by means of a standardized questionnaire.
Assessment of ACE Genotype
DNA was isolated from frozen whole blood containingEDTA as anticoagulant by a standard salting-out procedure.and was resuspended in a it ( 10 mM Tris/ 1 mM EDTA, pH7.6) buffer. Genomic DNA (approximately 0.25 �.tg) was am-plified by polymerase chain reaction in a 50-g.tL reactionmixture containing 10 mM Tris-HC1. pH 8.8. 50 mM KCI. 1.5mM MgCb2. 0.1% TrIton X-100 (Sigma Chemical Co., St.Louis, MO). 200 �.tM each dATP. dCTP. dGTP. dTTP, 0. 1 2 �tMeach primer, and 0.5 U thermostable DNA polymerase (Dy-nazyme. Espoo, Finland). The mixture was overlaid withmineral oil. In any given set of reactions. a negative control
containing no genomic DNA and a positive control of known
genotype were always included. The amplification was ob-
tamed after the following steps: 5 mm of denaturation at
95#{176}C.followed by 30 cycles of 1 mm at 94#{176}C.1 mm at 58#{176}C.and 2 mm of DNA synthesis at 72#{176}C.First, all of the sampleswere analyzed using a pair of primers that amplilv the entireintron 16. as already reported ( 1 1). To avoid ID/DD mistyp-ing. a pair of primers that amplify a region inside intron 16were also used to analyze all samples showing DD genotypeas described (7). The samples were visualized after electro-phoresis on a 2% agarose gel and ethidium bromide staining.
Investigators were blinded as to type when genotyping was
undertaken.
Microalbuminuria
The presence of microalbuminurla was evaluated. at theend of the wash-out period (if any) as the albumin-to-creatinine ratio (A/C) on three nonconsecutive. first morning
urine samples. Only samples from patients with a negative
urine culture were collected. Whenever a positive urine cul-
ture was found. urine samples were discarded, appropriateantibacterial treatment was instituted, and urine collectionsfor albuminuria were repeated only after a second culturetested negative. The A/C was calculated as follows: urinaryalbumin concentration (milligram per liter)/urinary creati-nine concentration (mmol per liter). Serum and urine creat-
mine levels were determined by the routine Jaffe’s reaction.Urine albumin concentration was measured by a commer-cially available RIA kit (Sclavo. Ciniselbo Balsamo. Italy). An
A/C between 2.38 and 19 (men) and between 2.96 and 20
ACE Gene and Organ Damage in Hypertension
2552 Volume 7 - Number 12 - 1996
(women) was used to define microalbuminuria. These criteriaproved to have good sensitivity and specificity in the detec-
tion of albumin excretion rate between 20 and 200 ug/min(12). The average of each patient’s three A/C was used toIndicate the level of albumin excretion.
Retinopathy
The presence, type. and extent of hypertensive retinopathywere Investigated in a darkened room and under pupil
dilatation. Direct ophthalmoscopy was carried out with a
halogen ophthalmoscope: the first arteriovenous crossing at
least one disc diameter from the disc in each quadrant wasselected and assessed. Each quadrant of the fundus wasphotographed by means of a Zeiss fundus camera(Oberkochen. Germany) with a 30#{176}field. Photographic slideswere projected and evaluated by the same ophthalmologist.who was unaware of the patients’ clinical data. Retinalfeatures sought were venule nipping. venube deviation, andlight reflex change at all clearly visualized crossings with
comparably sized arterioles at least one disc diameter from
the disc. The mean ratio of diameters of equivalent-orderarterioles and venules in each quadrant was measured andthe presence of focal arterlolar narrowing. hemorrhages.exudates. and papilledema was sought. Retinal lesions wereclassified according to Keith-Wagener-Barker classification
(13).
Echocardiography
All echocardiographic studies were performed using an
Acuson XP-128 ultrasound machine (Mountain View. CA).
Echocardiograms were obtained at rest with patients supinein the left lateral position. by using standard parasternal andapical views. The overall monodimensionab left ventricularmeasurements and the bidimensional (apical four and twochamber) views were obtained according to the recommen-dations ofthe American Society ofEchocardiography (14.15).
All tracings were obtained and read by a single observer who
was blinded to the clinical characteristics of the patients
under observation. Left ventricular mass was derived fromthe formula described by Devereux and associates (16):
LV mass (g) = 0.80 x 1 .04 [(VSTd + LVIDd + PWTd)3-(LVIDd)3j + 0.6
where VSTd is ventricular septal thickness at end diastole,LVIDd Is LV internal dimension at end diastole. and PWI’d isLV posterior wall thickness at end diastole. Left ventricularmass was corrected for body surface area (LVMI), and ex-pressed in units of grams/meter squared (g/m2). The pres-ence of left ventricular hypertrophy (LVH) was defined forLVMI �l34 g/m2 (men) and �110 g/m2 (women) (17). Nopatients showed dyssynergic areas that would invalidate thetheoretical assumptions behind the cardiac mass calcula-
tions.
Statistical Analysis
All data are expressed as mean � SE. Differences betweenvariables were assessed using the appropriate statistical testbased on the underlying distribution of the variables. One-way analysis of variance (ANOVA) with multiple comparisonpost-test were used to analyze data from patients with thethree ACE genotypes. Either a nonparametric (Welch’s I test)or a parametric (Student’s I test) test was used to assess
differences between patients with DD+ID and II genotypes.
Differences between prevalences were assessed by chi-
squared test or Fisher’s exact test as appropriate. The calcu-bation of odds ratios was performed to provide an estimate ofthe relative risk of microalbuminuria, retinopathy, and leftventricular hypertrophy in groups of patients with different
genotypes. Piecewise linear regression analysis was per-formed to assess the contribution of ACE genotype and othervariables on albumin excretion. This analysis may provide a
better assessment of data when the nature of the relation-
ship between one or more independent variables and adependent variable changes over the range of the dependentvariable. It also permits the identification of the point where
discontinuity in the regression line occurs (i.e. , the break-
point of the regression) ( 1 8). MultIple regression analysis wasperformed to assess the independent contribution of ACEgenotype (II = 0, ID+DD = 1 ) and other variables on thepresence of retinopathy and left ventricular hypertrophy. AK-means cluster analysis was performed on the entire cohort
of patients to identify different subgroups of patients accord-ing to the presence / absence of target organ damage and ACE
D genotype (II = 0, DD+ID = 1 ). The appropriateness of theclassification has been assessed by performing a standardbetween-group analysis of variance for each variable ( 1 9). Allstatistical analyses were performed using SAS (SAS Institute,Cary. NC) and Statistica (Statsoft Inc. , Tulsa, OK) software.
RESULTS
The observed overall genotype distribution (DD,
27%; ID. 50%; and II 23%) was consistent with Hardy-
Weinberg equilibrium and similar to previous reports
in caucasian populations (20). There was an overall
frequency of 54% for the D allele and 46% for the I
allele, which compares closely with other white popu-
latlons studied (2 1 ). The overall prevalence of ml-
croabbummnunia. retinopathy. and left ventricular hy-
pertrophy were 19, 74, and 72%, respectively. Therewere no differences in age, prevalence offamiby history
for hypertension. current smokers, known duration of
disease. BMI. blood pressure. serum glucose, uric
acid, and lipid profile when patients were divided
according to their genotype (Table 1).
Patients with DD and ID genotypes were signifi-
cantly more likely to be microalbuminunic (DD, 37%;
ID, 26%; II, 6%; chi-squared. 6.74, P 0.034; chi-
squared for trend, 6.50, P = 0.0 1 ; Table 1 ) and showedhigher levels of A/C (DD. 3.6 ± 0.9; ID, 2.6 ± 0.7; II,
0.9 ± 0.2 mg/mmob; P = 0.027 by ANOVA; Table 1)
compared with II patients. The odds ratio for the
presence of microabbuminunia was 8.51 (95% confi-
dence interval. 1.07 to 67�85, P = 0.019; Figure 1) in
patIents with DD and ID genotypes. The frequency of D
allele was significantly higher in patients with mi-
croabbuminunia (0.69 versus 0.46; odds ratio, 2.59;
95% confidence interval, 1.24 to 5.41; P 0.013;
Table 2) compared with subjects who were nor-
moabbuminuric. A piecewise linear regression anaby-
515 was performed among the entire cohort of patients
to identify factors that independently influence A/C. A
two-slope linear model was identified with a break-
point value of 2.4, almost identical to the one pre-
defined to indicate the passage from normo- to mi-
croalbuminunia. Age, BMI, LDL cholesterol, and ACE
genotype significantly influence A/C levels and to-
100
50-
0 10
� 5.
(I,0001
8.5
5.2 5.2
Pontremoli et al
Journal of the American Society of Nephrology 2553
TABLE 1 . Clinical characteristics of patients according to ACE gene polymorphisma
CharacteristicACE Gene Polymorphism
DD ID II pb
Number of Patients 29 53 24Male/Female 18/1 1 28/25 15/9 NSAge 43.6 ± 2.2 49.7 ± 1.3 47.0 ± 1.9 NSDuration of Disease (months) 47.6 ± 9.3 60.7 ± 8.2 59.2 ± 13.0 NSFamily History of Hypertension (%) 84 65 57 NSCurrent Smokers (%) 52 38 40 NSSBP (mm Hg) 164 � 3 161 ± 2.9 154 � 2.9 NSDBP (mm Hg) 106 ± 1.3 103 ± 1.0 102 ± 1 . 1 NSMBP(mmHg) 125± 1.6 122± 1.4 119t 1.5 NSBody Mass lndexc 27.7 ± 0.83 27.0 ± 0.57 26.6 � 0.9 NSFasting Blood Glucose (mg/dL) 87.5 ± 1.7 91 .0 ± 1.8 94.7 ± 2.5 NSUric Acid (mg/dL) 5.3 ± 0.3 5.4 ± 0.2 5.3 ± 0.4 NSTriglycerides (mg/dL) 128 � 11 130 ± 9 107 ± I 1 NSTotal Cholesterol (mg/dL) 220 ± 10 212 ± 6 214 ± 7 NSHDL Cholesterol (mg/dL) 46 ± 3.7 49 ± 2.0 50 ± 2.7 NSLDL Cholesterol (mg/dL) 154 ± 9.9 133 ± 5.2 143 ± 6.5 NSUrinary Na (mmol/day) 173 ± 17 156 ± 14 147 ± 20 NSA/C (mg/mmol) 3.6 ± 0.9 2.6 ± 0.7 0.9 ± 0.2 0.027Prevalence of Microalbuminuria (%) 37 26 6 0.034Prevalence of Retinopathy (%) 83 80 44 0.009LVMI (g/m2) 154 ± 8.0 151 � 6.0 133 � 5.7 0.132Prevalence of LVH (%) 74 83 33 0.015
a Data are mean ± SE.ACE. angiotensin-converting enzyme; SBP. systolic blood pressure; DBP, diastolic blood pressure; MBP. mean blood pressure;HDL high-densitylipoprotein; LDL low-densityiipoprotein; A�. albumin/creatinine ratio; LvMl. left ventricular mass. corrected for body surface area;LVH, left ventricular hypertrophy; NS, not statistically significant.b p values were calculated by one-way analysis of variance or chi-squared test as appropriate.C Calculated by dividing the weight in kilograms by the square of the height in meters.
0.1Mlcroalbumlnuria Retinopathy LVH
Figure 1 . Relative risk of microalbuminurla, retinopathy, andleft ventricular hypertrophy in patients with essential hyper-tension and ACE DD and ID genotypes. Patients with ACE 0genotypes (00 + ID) are more likely to have target organdamage than patients with ACE II genotype. LVH, left yen-tricular hypertrophy.
gether account for over 75% of variations in albumin-
uria (Table 3).
Hypertensive retinopathy was present in patients
with DD and ID genotypes significantly more often(DD, 83%; ID, 80%; II, 44%; chi-squared, 9.47. P =
0.009: chi-squared for trend, 6.73. P 0.009; Table 1)
than in II patients. The odds ratio for the presence ofhypertensive retinopathy was 5. 19 in patients with DD
and ID genotypes (95% confidence Interval, 1 .7 1 to
15.75, P = 0.005; Figure 1). The frequency ofD allele
was significantly higher In patients with hypertensive
retinopathy (0.59 versus 0.37; odds ratio, 2.44: 95%
confidence interval, 1.21 to 4.90, P = 0.015; Table 2).
Multiple regression analysis performed among the
entire cohort of patients demonstrated that ACE ge-
notype (P <0.01), age (P <0.01), and A/C (P <0.02)
significantly and independently influence the pres-
ence of retinopathy and together account for about
30% of variations In retinal status (r� = 0.292, Table
4).
DD and ID genotypes were associated with a signif-
icantly higher prevalence of left ventricular hypertro-
phy (DD. 74%; ID. 83%; II. 33%; chi-squared. 8.96. P =
0.0 1 ; Table 1 ). Patients with DD and ID genotypes
showed increased LVMI ( 1 52 ± 5 versus 1 33 ± 6
g/m2. p o.oi. Table 1; odds ratio for the presence of
left ventricular hypertrophy. 5.22; 95% confidence
interval, 1.52 to 17.94, P = 0.016; FIgure 1) compared
with II patients. Multiple regression analysis demon-
strated that ACE genotype (P < 0.03) and total cho-
besterob (P < 0.05) sIgnificantly and independently
influence the presence of left ventricular hypertrophy
ACE Gene and Organ Damage in Hypertension
2554 Volume 7 - Number 12 - 1996
TABLE 2. 0-! allele frequency in essential hypertensive patients with and without target-organ damage#{176}
ParameterAllelic Frequency
Alb+ AIb- Ret+ Ret- LVH+ LVH-
0 0.69 0.46 0.59 0.37 0.60 0.50I 0.31 0.54 0.41 0.63 0.40 0.50Odds Ratio 2.59 2.44 1.5295% Confidence Interval 1 . 24 to 5.41 1.21 to 4.90 0.71 to 3.26PValue 0.013 0.015 0.330
a Alb+ and AIb- indicate patients with and without microalbuminuria. Ret+ and Ret- indicate patients with and without retinopathy. LVH+ andLvH- indicate patients with and without left ventricular hypertrophy. The relative risk for organ damage in patients with 0 allele was calculated byFisher’s exact test.
TABLE 3. Significant determinants ofmicroalbuminuria in essential hypertension(piecewise linear regression analysis)a
IndependentVariables
Regression Coefficient
Below AboveBreakpoint Breakpoint
AgeBMI
-0.00120.0239
0.41500.4876
LDLChoI -0.0005 0.0514ACE -0.1843 3.206
a Dependent variable: albuminuria (A/C); independent variables:Age. BMI, LDL Chol. ACE genotype. Breakpoint = 2.4 Regressiondegrees of freedom = 4-16. F = 3.oo, P -0.026. r� = 0.775. A/Cindicates urinary albumin-to-creatinine ratio (mg/mmol); BMI, bodymass index; LDL Chol. LDL cholesterol (mg/dL); ACE, angiotensin-converting enzyme genotype (II = 0. ID + DO = 1).
TABLE 4. Multiple regression analysis of retinopathy0
IndependentVariables
/3 SE� Partial F P
ACE 0.307 0.116 10.80 0.010Age 0.296 0.111 8.63 0.010A/C 0.268 0.116 7.98 0.024
a Dependent variable: retinopathy: independent variables = ACEgenotype. Age. A/C. Regression degrees of freedom = 3-58. F =7.977. p = 0.00015. Intercept = -0.247; r� = 0.292. ACE indicatesangiotensin-converting enzyme genotype (II = 0. ID + DO = 1); A/C.urinary albumin-to-creatinine ratio (mg/mmol).
and together account for about 25% of its variations
(r2 = 0.236, Table 5).
Patients with DD and ID genotypes showed a re-
markabby higher percentage of either at beast two
(odds ratio, 9.333; 95% confidence interval, 2.373 to
36.717. P = 0.0006: data not shown) or all three
cardiovascular abnormalities investigated in this
study (odds ratio. 15.9; 95% confidence interval,
0.9038 to 280.05, P = 0.007; data not shown). Fur-
thermore, the D allele entails a threefold risk of having
either at least two (odds ratio, 2.483: 95% confidence
interval. 1 .26 1 to 4.888. P < 0.0 1 1 ; data not shown) or
all three of the above-mentioned abnormalities (odds
ratio. 3.333; 95% confidence interval. 1.425 to 7.795,
TABLE 5. Multiple regression analysis of leftventricular hypertrophy0
IndependentVariables 13 SEI3 Partial F P
ACE 0.361 0.160 4.40 0.031Chol 0.334 0.160 4.62 0.04
a Dependent variable: left ventricular hyperfrophy; independent van-
ables: ACE genotype. chol. Regression degrees of freedom = 2 to 30.F = 4.623, P = 0.178. Intercept = -0.290; r� = 0.236. ACE indicatesangiotensin-converting enzyme genotype (II = 0. ID + DD = 1); Chol,serum total cholesterol (mg/dL).
TABLE 6. Multi-way, between-groups analysis ofvariance and contrast analysis of the prevalence oftarget-organ damage and ACE genotypes (I! = 0,DD + ID = 1) in patients with essential hypertensiondivided into three clusters according to K-meanscluster analysisa
Variable df F P
Retinopathy 2 to 59 3.944 0.025Microalbuminuria 2 to 59 4.414 0.016ACE Genotype 2 to 59 4.330 0.017Left Ventricular Hypertrophy 2 to 59 19.330 0.005
a The three clusters differ significantly for the presence/absence of
target organ damage and ACE genotype. df. degrees of freedom.
P = 0.006; data not shown). K-means cluster analysis
of the entire cohort of patients allowed us to identify
three subgroups that differ significantly (Table 6) for
the presence (or absence) of retinopathy, microabbu-
minuria, left ventricular hypertrophy, and the fre-
quency ofDD or ID genotype (Figure 2), while showing
no difference as far as other clinical and biochemical
parameters are concerned. Patients in Cluster 2 (N =
15) show a lower than average frequency of ACE DD
and ID genotypes as well as bow prevalence of mi-
croabbuminuria and left ventricular hypertrophy. Pa-
tients in Cluster 1 (N = 3 1 ) show a frequency of DD
and ID ACE genotypes similar to the average of the
entire population and are characterized by a lower
prevalence of microabbuminuria but higher preva-
bence of left ventricular hypertrophy. Finally, patients
100
75
�‘\ ...., -o-clusterl(n31)
50 “� .�.‘ “\ -.- clusteq’ 2 (n15)
2: ‘\.,%, � �.\.\\.:i.ciuster 3 (n=16)
Pontremoli et al
Journal of the American Society of Nephrology 2555
ret. ME ACE. LVH
Figure 2. Plot offrequency oftarget organ damage and ACE0 genotype in patients with essential hypertension dividedaccording to K-means cluster analysis. K-means cluster anal-ysis was performed among the entire cohort of patients.Three different subgroups were identified accordin9 to the
prevalence of target organ damage and the frequency ofACE genotype. Ret + indicates the presence of hypertensiveretinopathy; Mi, microalbuminuria; ACE +, angiotensin-
converting enzyme genotypes DO and ID: LVH, left ventricu-lar hypertrophy. The three clusters differ significantly for eachvariable examined (see Table 6).
in Cluster 3 are characterized by a very high frequency
of ACE DD and ID genotypes associated with a high
prevalence of retinopathy. microalbuminuria, and left
ventricular hypertrophy (Figure 2).
DISCUSSION
The principal finding of this study is that essential
hypertensive patients with DD and ID genotypes of the
ACE gene show a greater prevalence of target organ
damage. The D allele seems to confer an increased risk
for the development of microalbuminuria and retmnop-
athy independently of blood pressure values as well as
other commonly acknowledged cardiovascular risk
factors, namely age. smoking habits, family history
and known duration of hypertension, body mass in-
dex, lipid profile, uric acid, and fasting blood glucose.
Although the DD genotype has been reported to be a
risk factor for left ventricular hypertrophy (3,4) and
ischemic and degenerative heart disease (22) In the
general population, and for a more rapid progression
of renal failure in nondiabetic renal disease (23,24),
this Is, to our knowledge. the first time that It has been
reported in association with the development of mul-
tiple organ damage in essential hypertension. Our
findings also support previous evidence that the re-
nmn-angiotensin-aldosterone system may play an im-portant role in the pathophysiobogy of vascular and
tissue damage in essential hypertension (1.25).In the study presented here, the prevalence of ml-
croalbuminurla, retinopathy. and left ventricular hy-
pertrophy was comparable with what has been re-
ported in the literature (26-29).
Earlier studies have shown a high prevalence of
retinopathy in patients with essential hypertension
(27). Retinal changes are thought to reflect vascular
and tissue damage and thereby the risk of future
vascular events. In fact, hypertensive retinopathy has
been previously reported to be an independent indica-
tor of all-causes mortality (30). In the study presented
here, patients with DD and ID genotypes had a fivefold
greater risk for retinopathy (Figure 1) compared with II
patients. The presence of the D allele entails a twofold
greater risk for retinopathy (Table 2). Patients with
Grades 1 and 2 lesions were analyzed together be-
cause of the substantial overlapping of the retinal
features described (Table 1 ). However, when the sever-
ity of retinal changes was taken into consideration, a
significant assocIation with DD and ID genotypes was
still present (chi-squared, 10.9, P = 0.028; data not
shown). Furthermore, the frequency of D allele was
higher in patients with more severe degrees of retmnop-
athy (chi-squared, 10.3, P = 0.006; chl-squared for
trend, 4.55, P 0.033: data not shown). Multipleregression analyses demonstrated that the ACE poly-
morphism Independently contributes to the presenceof retinopathy and accounts for a significant part of
variation in retinal status (Table 4).
Increased left ventricular mass is a webb-known,
powerful, independent predictor of cardiovascular
morbidity and mortality in hypertension (3 1-33) and
is thought to be a consequence of left ventricular
pressure overload (34-36). The relatively high preva-
bence of left ventricular hypertrophy In our study
(Table 1 ) Is comparable to the one previously reported
in the literature when similar sensitive and specific
techniques were used (37.28). In the study presented
here, patients with DD and ID genotypes had a higher
probability ofhaving left ventricular hypertrophy corn-
pared with II patients (Figure 1 . Table 1 ). When ana-
lyzed together, DD and ID patients showed increased
LVMI compared with II patients (151.9 ± 5 versus
133.2 ± 5 g/m2, P = 0.01; data not shown). Multiple
regression analyses demonstrated that ACE genotype
is an independent predictor of the development of left
ventricular hypertrophy and accounts for a significant
part ofvariation in cardIac mass (Table 5). At present.
data on the relationship between ACE gene and left
ventricular hypertrophy are controversial. A recent
study on a barge group of subjects from the Framing-
ham Heart Study failed to show a role of the ACE gene
in influencing left ventricular mass (38). However, the
results presented here are in accordance with previ-
ous studies reporting an association between the DD
genotype of ACE and the risk of left ventricular hyper-
trophy In the general population including patients
with hypertension (4.5). These contrasting results can
be explained at least in part by the nonuniform genetic
background of study populations and by the possible
confounding effect of antihypertensive treatment.
Although hypertensive retinopathy and left ventric-
ubar hypertrophy have long been regarded as lrnpor-
tant complications of hypertension and predictors of
cardiovascular death, the robe of microalbuminuria as
an important and independent cardiovascular risk
factor or more likely as a marker itself of diffuse
ACE Gene and Organ Damage in Hypertension
2556 Volume 7 - Number 12 - 1996
endothelial vascular damage has only been acknowl-
edged over the last few years. Several investigators
have shown that microalbuminuria is a predictor ofcardiovascular events in hypertensive patients
(29,39). In the 10-yr Goteborg follow-up study (40),
the predictive power of abbuminuria exceeded that of
total serum cholesterol and other cardiovascular risk
factors. More recently, other authors have shown that
In essential hypertension, microalbuminuria is asso-
elated with a higher degree of left ventricular hyper-
trophy (29,4 1 ) as well as hypertensive retinopathy
(27). These data support the conclusion that ml-
croalbuminuria is a marker for early end-organ and
cardiovascular damage in such patients. In the study
presented here. patients with DD and ID genotypes not
only showed higher levels of albuminuria but also a
significantly higher prevalence of microalbuminuria
compared with II patients (Table 1 ). DD and ID geno-
types were associated with an 8.5 times greater prob-
ability of microabbuminuria compared with II patients
(Figure 1 ). Piecewise linear regression analysis dem-
onstrated that ACE genotype, together with age, BMI,
and LDL cholesterol. strongly and independently in-
fluence variations in albumin excretion (Table 3). In-
terestingly, all these independent variables are posi-
tively related to A/C only above the breakpoint of the
regression line, thus indicating that their contribution
to variations In albumin excretion changes and is
more evident in patients with persistent microabbu-
rninuria. When taken together. these data strongly
suggest a robe for ACE gene polymorphism as a poten-
tial genetic risk factor for cardiovascular damage.
Several reasons make the ACE gene, among the
renin-anglotensin genes, one of the major etiobogical
candidates for the development of cardiovascular in-jury. First, the gene is highly expressed in endothelial
cells and in the heart. Second, the bevels of ACE in
plasma and inside the cells show quantitative varia-
tions related to gene polymorphism. An increased
enzyme concentration, associated with the DD and ID
genotypes, may lead to an increase in All generation
and bradykinin degradation. Bradykmnin acts on en-
dothelial �2-kinin receptors and is able to stimulate
nitric oxide formation by endotheliab nitric oxide-syn-
thetase and prostacycbmn synthesis. Furthermore. ex-
perirnental studies suggest that All may stimulate
cardiac protein synthesis (42-44) whereas bradykinin
may have an antiproliferative effect (45.46). Moreover,
lID ACE polymorphism was shown to modulate the
intracellular bevel of ACE in T lymphocytes (47). In
addition, recent studies have demonstrated elevated
cardiac expression of ACE messenger RNA and ACE
activity in experimental animals with pressure-over-
load left ventricular hypertrophy (46,48) and in pa-
tients with heart failure (49). Therefore it is tempting
to speculate that, in patients with DD genotype. higher
ACE activity In cardiac and vascular tissues might
facilitate cellular hypertrophy, extraceblubar matrix
formation (50.5 1 ), and sympathetic neurotransmis-
slon (52). All of the above might contribute to the
development of vascular and tissue damage in essen-
tial hypertension. The results of the study presented
here are in accordance with previous observations,suggesting that increased activity of the renin-angio-
tensin-aldosterone system might play a robe in the
development of target organ damage in essential hy-
pertension. Erley et at. (53) demonstrated the pres-
ence of altered renal hemodynamics and higher prey-
alence of left ventricular hypertrophy, retinopathy,
and microalbuminuria in young essential hyperten-
sive patients with hyperresponsivity of the renin-an-
giotensin-abdosterone system . Accordingly. Alderman
et at. (25) showed that plasma renin activity is an
important and independent risk factor for cardiovas-
cubar complications in a barge number of patients with
essential hypertension, prospectively followed-up for
several years. The fact that in our study the associa-
tion of microalbuminuria, retinopathy. and left yen-
tricular hypertrophy was found far more often in
patients with the ACE D allele is intriguing, because
these three different expressions of early organ dam-
age may be regarded as the end point of pathophysi-
obogical processes, promoted at beast in part by in-
creased angiotensin II bevels. This conclusion seems to
be supported by results of K-means cluster analysis.
which identifies three distinct subgroups differing
significantly in both the frequency of ACE genotype
and in the prevalence of organ damage. Patients with
a high frequency ofDD and ID ACE genotypes (Cluster
3, Figure 2 and Table 6) show a remarkably higher
prevalence of retinopathy, microalbuminuria, and left
ventricular hypertrophy, whereas those with a bow
frequency of the D allele (Cluster 2) seem to be pro-
tected from developing organ damage.
Finally, salt intake has been shown to be related to
both left ventricular hypertrophy and microalbumin-
uria in hypertensive patients (54). In the study pre-
sented here, there was no difference in urinary Na
excretion among the three groups of patients accord-
Ing to ACE genotypes (Table 1 ). However, the study
design does not allow us to exclude a contribution of
dietary salt intake in the development of target organ
damage.
Although the data presented need to be interpreted
with some caution because of the limited number of
patients studied. both the homogeneity of the genetic
background (all patients were of Caucasian origin)
and the frequency of different ACE genotypes, which
was almost identical to the one previously reported in
larger studies on Caucasian patients, led us to believe
that our patients are representative of a larger popu-
bation with essential hypertension.
In conclusion, the results of this study suggest that
the deletion polymorphism of the ACE gene might be
an independent risk factor for the development of
organ damage in hypertensive patients. From a clini-
cab perspective. this implies the possibility of early
identification of patients at increased risk for develop-
ment of target organ damage, by determining ACE
polymorphism. Therefore, a greater effort can be made
Pontremoli et al
Journal of the American Society of Nephrology 2557
to prevent cardiovascular complications and to treat
hypertension and other modifiable risk factors in
these patients. Whatever the underlying molecular
mechanisms linking the ACE-gene polymorphism to
the development of target organ damage may be. the
determination of the ACE genotype could be helpful in
the assessment of cardiovascular risk and in planning
treatment strategies in patients with essential hyper-
tension. Large longitudinal trials are needed to actu-
ably determine the incidence of target organ damage
and cardiovascular complications in patients with
high-risk genotypes and to clarify whether antihyper-
tensive agents that directly exert their action on the
renmn-angiotensmn system may provide additional or-
gan protection beyond blood pressure control.
ACKNOWLEDGMENTWe are grateful to Giacomo Morreale for technical assistance.
REFERENCES
1. Laragh JH: Renin profiling for diagnosis, risk assess-ment. and treatment of hypertension. Kidney Int 1993:44: 1 163-i 175.
2. Rigat B, Hubert C. Alhenc-Gelas F, Cambien F. Corvol P.Soubrier F: An insertion/deletion polymorphism in theangiotensmn I-converting enzyme gene accounting for halfthe variance of serum enzyme levels. J Clin Invest 1990;86:1343-1346.
3. Tiret L, Brigitte R, Visvikis S, et at.: Evidence, fromcombined segregation and linkage analysis. that a van-ant of the angiotensmn I converting enzyme (ACE) genecontrols plasma ACE levels. Am J Hum Genet 1992:51:197-205.
4. Schunkert H, Hense HW, Holmer SR. et at.: Associationbetween a deletion polymorphism of the angiotensinconverting enzyme gene and left ventricular hypentro-phy. N Engl J Med l994;330:l634-1638.
5. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DDgenotype of the angiotensin converting enzyme gene is arisk factor for left ventricular hypertrophy. Circulation1994:90:2622-2628.
6. Cambien F, Poirier 0, Lecerf L, et al.: Deletion polymon-phism in the gene for angiotensin converting enzyme is apotent risk factor for myocardial infarction. Nature(Lond) 1992:359:641-644.
7. Nakal K, Itoh C, Miura Y, et at.: Deletion polymorphismof the angiotensin-I converting enzyme gene is associatedwith serum ACE concentration and Increased risk forCAD in the Japanese. Circulation 1994;90:2199-2202.
8. Ruiz J. Blanche H, Cohen N, et at.: Insertion/deletionpolymorphism of the angiotensin-converting enzymegene is strongly associated with coronary heart diseasein non-insulin dependent diabetes meblitus. Proc NatlAcad Sci USA 1994;91:3662-3665.
9. Lindpaintner K, Pfeffer MA, Kreutz R, et at.: A prospec-tive evaluation of an angiotensmn-converting-enzymegene polymorphism and the risk of ischemic heart dis-ease. N Engb J Med 1995:332:706-71 1.
10. Friedewald WT, Levy RI, Fredrickson DS: Estimation ofthe concentration of low density lipoprotemn cholesterolIn plasma without use ofthe preparative ultracentnifuge.Clin Chem l972;18:499-502.
1 1 . Rigat B, Hubert C, Corvol P. Soubrier F: PCR detection ofthe insertion/deletion polymorphism of the human an-giotensin converting enzyme gene (DCP 1) (dipeptldybcar-boxypeptidase 1). Nucleic Acids Res 1992:20:1443.
12. Mangili R, Deferran G, Di Mario U, et aL: Prevalence ofhypertension and microalbuminuria in adult type 1(insulin dependent) diabetic patients without renal fail-ure in Italy: Validation of screening techniques to detectalbuminunia. Acta Diabetol 1992:29:156-166.
13. Keith NM, Wagener HP, Barker MW: Some different
types of essential hypertension: Their course and prog-nosis. Am J Med Sd 197;1939.332-343.
14. Sahn DJ, De Maria A, Kisslo J, Weyman A: Recommen-dations regarding quantitation in M-mode echocardiog-raphy: results ofa survey ofechocardiographic measure-ments. Circulation 1978;58: 1072-1083.
15. Schiller NB, Shah PM, Crawford M, et at.: Recommen-dations for quantitation of the left ventricle by twodimensional echocardiography: American Society ofEchocardiography Committees. J Am Soc Echo l989;55:358 -367.
1 6. Devereux RB, Reichek N: Echocardiographic determina-tion of left ventricular mass in man: Anatomic validationof the method. Circulation 1977;55:613-6l8.
1 7. Devereux RB: Detection of left ventricular hypertrophyby M-mode echo-cardiography: Anatomic validation,standardization, and comparison to other methods. Hy-pertenslon 1987;9lSuppb III: 19-26.
18. Weisberg S. Applied Linear Regression. New York: Wiley;1980.
19. Tryon RC. Bailey DE. Cluster Analysis. New York:McGraw-Hill; 1970.
20. Harrap SB, Davidson HR. Connor JM, et at.: The angio-tensin I converting enzyme gene and predisposition tohigh blood pressure. Hypertension 1993;2l:455-460.
2 1 . Morris BJ, Zee RYL, Schrader AP: Different frequenciesof anglotensin-converting enzyme genotypes in olderhypertensive individuals. J Clin Invest 1994:94:1085-1089.
22. Raynolds MV, Bristow MR. Bush EW. et at.: Angioten-sin-converting enzyme DD genotype in patients withischaemic or idiopathic dilated cardiomyopathy. Lancet1993:342:1073-1075.
23. Hamogouchi A, Yoshida H, Miyazaki Y. Kawamura T,Mitarai T, Sakai 0: The deletion polymorphism of theACE gene is a risk factor for the progression to renalfailure independent of the M2357 polymorphism in theangiotensinogen gene IAbstractl. J Am Soc Nephrol1995;6:389A.
24. Yoshida H, Mitari T, Kawamura T, et at.: Role of thedeletion polymorphism of the angiotensin convertingenzyme gene in the progression and therapeutic respon-siveness of IgA nephropathy. J Clin Invest 1995:96:2 162-2 169.
25. Alderman MH, Madhavan 5, Ooi WL, Cohen H, Sealy JE,Laragh JH: Association of the renin sodium profile withthe risk of miocardial infarction in patients with hyper-tension. N Engl J Med 1991 :324: 1098-1 104.
26. Ritz E, Nowicki M, Fliser D, Homer D, 1(11mm HP:Proteinurla and hypertension. Kidney Int 1994;46ISuppl47l:S76-S80.
27. Biesenbach G, Zazgornik J: High prevalence of hyper-tensive retinopathy and coronary heart disease in hyper-tensive patients with persistent microalbuminunla un-der short intensive antihypertensive therapy. ClinNephrol 1994;41:21 1-2 18.
28. Savage DD, Drayer JIM. Henry WL. et at.: Echocardlo-graphic assessment of cardiac anatomy and function inhypertensive subjects. Circulation 1 979;59:623- 632.
29. Cerasola G, Cottone S D’Ignoto G, et at.: Microabbumin-uria as a predictor of cardiovascular damage In essentialhypertension. J Hypertens 1 989;7lSuppl 61:S332-S333.
30. Schouten EG, Vandenbroucke JP, Van Der Heide-Wessel C, Van Der Heide RM: Retinopathy as an Inde-pendent indicator of all-causes mortality. Int J Epide-miol 1986;15:234-236.
3 1 . Kannel WB. Gordon T, Castelli WP, Margolis JR: Elec-trocardiographic left ventricular hypertrophy and risk ofcoronary heart disease: The Framingham Study. AnnIntern Med 1970;72:813-822.
32. Levy D, Garrison RI. Savage DD, Kannel WB, CastelliWP: Prognostic implications ofechocardiographically de-termined left ventricular mass in the Framingham HeartStudy. N Engi J Med 1990;322:1561-1566.
33. Sullivan JM, Vander Zwaag R, el-Zeky F, RamanathanKB, Mirvis DM: Left ventricular hypertrophy: Effect onsurvival. J Am Cobb Cardiol 1993;22:508-513.
34. Levy D, Anderson KM, Savage DD. Kannel WB, Chris-
ACE Gene and Organ Damage in Hypertension
2558 Volume 7 - Number 12 - 1996
tiansen JC, Castelli WP: Echocardiographically detectedleft ventricular hypertrophy-prevabence and risk fac-tors: The Framingham Heart Study. Ann Intern Med1988; 108:7-13.
35. Grossman W, Jones D, McLaurin LP: Wall stress andpatterns of hypertrophy in the human left ventricle.J Clin Invest l975;56:56-64.
36. Ganau A, Devereux NP, Pickering TG, et at.: Relation ofleft ventricular hemodynamic load and contractile per-formance to left ventricular mass in hypertension. Cir-culation 1990:81:25-36.
37. Devereux RB: Echocardiographic insights into thepathophysiology and prognostic significance of hyper-tensive cardiac hypertrophy. Am J Hypertens l989;2:1865-1955.
38. Lindpainter K. Lee M, Larson MG, et at.: Absence ofassociation or genetic linkage between the angiotensmn-converting-enzyme gene and left ventricular mass.N En�l J Med l996;334:1023-l028.
39. Yudkin JS, Forrest RD, Jackson C: Microabbuminuriaas predictor of vascular disease in nondiabetic subjects.Lancet 1988;2:530-533.
40. Samuelsson 0, Wilhelmsen L, Elmfeldt D, et at.: Pre-dictors of cardiovascular morbidity in treated hyperten-sion: Results from the primary preventive trial in G#{246}te-borg. Sweden. J Hypertens 1985:3:167-176.
4 1 . Schmiedr R, Grube E, Ruddel H, Schiebush H, SchulteW: Microprotemnuria as a marker for target organ damagein essential hypertension. Klin Wochenschr 1990:68:256 -259.
42. Khairallah PA, Kanabus J: Angiotensmn and myocardialprotein synthesis. Perspect Cardiovasc Res 1983:8:337-347.
43. Katz AM: Angiotensmn II: Hemodynamic regulator orgrowth factor? J Mob Cell Cardiol 1990:22:739-747.
44. Sadoshima J, Izumo 5: Molecular characterization ofangiotensmn Il-induced hypertrophy of cardiac myocytesand hyperplasia ofcardiac fibroblasts: Critical role of theAT1 receptor subtype. Circ Res 1993:73:413-423.
45. Farhy RD, Ho KL, Carretero OA, Scicli AG: Kininsmediate the antiproliferative effect of ramipril in rat
carotid artery. Biochem Biophys Res Commun 1992;182:283-288.
46. Schunkert H, Dzau VJ, Tang 55. Hirsch AT, Apstein CS,Lorell BH: Increased rat cardiac angiotensmn convertingenzyme activity and mRNA expression in pressure over-load left ventricular hypertrophy: Effects on coronaryresistance. contractility and relaxation. J Clin Invest1990:86: 19 13-1920.
47. Costerousse 0, Allegrini J, Lopez M, Aihenc-Gelas F:Angiotensin I-converting enzyme in human circulatingmononuclear cells: genetic polymorphism of expressionin T-lymphocytes. Biochem J 1993:290:33-40.
48. Schunkert H, Jackson B, Tang 55, et at.: Distributionand functional significance of cardiac angiotensin con-verting enzyme in hypertrophied rat hearts. Circulation1993:87:1328-1339.
49. Studer R, Reinecke H, Muller B, Holtz J, Just H, DrexierH: Increased angiotensin I converting enzyme gene ex-presslon in the failing human heart: Quantification bycompetitive RNA-pobymerase chain reaction. J Clin In-vest 1994:94:301-310.
50. Villarreal FJ, Kim NN, Ungab GD, Printz MP, DillmannWH: Identification of functional angiotensin II receptorson rat cardiac fibroblasts. Circulation 1993;88:2849-2861.
5 1 . Schelling P. Fischer H, Ganten D: Angiotensin and cellgrowth: A link to cardiovascular hypertrophy? J Hyper-tens 1991;9:3-15.
52. Malik KU, Nasjletti A: Facilitation of adrenergic trans-mission by locally generated angiotensin II in rat mesen-teric arteries. Circ Res 1976:38:26-30.
53. Erley CM, Holzer M, Kramer BK, Risler T: Renal haemo-dynamics and organ damage in young hypertensive pa-tients with different plasma renin activities after ACEinhibition. Nephrol Dial Transplant 1992;7:216-220.
54. Liebson PR, Grandits G, Prineas R, et at.: Echocardlo-graphic correlates of left ventricular structure among844 mildly hypertensive men and women in the treat-ment of mild hypertension study (TOMHS). Circulation1 993;87:476-486.